Back

Combined activation of complement and coagulation is associated with myocardial injury in ST-elevation myocardial infarction

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Advancements in cardiovascular therapies for ST-elevation myocardial infarction: from molecular insights to clinical applications Inflammation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Karsten Engseth Kluge

Oslo University Hospital Rikshospitalet, Oslo (Norway)

9 More presentations in this session

Presentation thumbnail
Relationship between lipoprotein(a) and endogenous fibrinolytic status in patients with STEMI
Doctor J. Leader (Stevenage, GB)
Abstract Slides Video
Presentation thumbnail
The clinical characteristics and prognosis of patients with acute non-ST-segment elevation myocardial infarction complicated with impaired activity daily living
Professor K. Chen (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
ORBI risk score and inflammatory response in patients with acute ST-elevation myocardial infarction
Doctor J. Kunkel (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Angiotensin-II receptor type 1 and endothelin-1 receptor type A agonistic autoantibodies in patients with STEMI: new kids on the block
Doctor G. Civieri (Padova, IT)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of composite lipid indices in patients with acute coronary syndrome undergoing percutaneous coronary intervention
Professor A. Hernandez (Storrs, US)
Abstract Slides Video

Access the full session

Session thumbnail
Advancements in cardiovascular therapies for ST-elevation myocardial infarction: from molecular insights to clinical applications

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Complement Factor D is an independent prognostic marker in patients with chronic kidney disease in the UK-Biobank
thumbnail
Congress Presentation
The CRP Troponin Test (CTT) stratifies mortality risk in patients with Non-ST Elevation Myocardial Infarction (NSTEMI)
thumbnail
Congress Presentation
Angiotensin-II receptor type 1 and endothelin-1 receptor type A agonistic autoantibodies in patients with STEMI: new kids on the block

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources